WASHINGTON, D.C. — March 24, 2016 — The Sabin Vaccine Institute (Sabin) today announced the appointment of Amy Finan as its next chief executive officer, following a global search by its Board of Trustees. Finan, currently the senior vice president responsible for business development with the Biotechnology Innovation Organization (BIO), the world's largest membership organization representing biotechnology companies, academic institutions, and state biotechnology centers, will assume her new role with Sabin on April 18, 2016.
The press from the Global Network.
As a committed advocate for the billions of poor people still at risk from neglected tropical diseases (NTDs), the Global Network for Neglected Tropical Diseases (Global Network) must voice its disappointment over the proposed decrease in NTD funding announced this week in President Obama’s proposed budget request for Fiscal Year (FY) 2017.
On Oct. 30, 2015, delegations from the ministries of health of the BRICS member states — Brazil, Russia, India, China, and South Africa — gathered in Moscow, Russia, for the Fifth BRICS Health Ministers’ Meeting. The ministers discussed NTDs and made a resolution to “strive for achieving the Global 2020 NTD control and elimination goals, for universal coverage of everyone in need by 2030.”
The Global Network for Neglected Tropical Diseases (Global Network), an initiative of the Sabin Vaccine Institute (Sabin), and Sabin Foundation Europe, the UK partner of Sabin, released the following statement on the UK Parliament’s House of Commons debate, “Work of the UK in tackling malaria and neglected tropical diseases,” held on Oct. 27, in London.